AnGes Competitors and Similar CompaniesClear all

Lexicon Pharmaceuticals's competitors and similar companies include Ionis Pharmaceuticals.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Founding Date
Founding Date
1995
Founding Date
1989
Type
Type
Public
Type
Public
Tags
Locations
Locations
The Woodlands, US HQ
Jersey, JE
Atlanta, US
Bernards, US
Birmingham, US
Boston, US
Charlotte, US
see more
Locations
Carlsbad, US HQ
Vancouver, CA
Stuttgart, DE
Dublin, IE
Dublin, IE
Lisboa, PT
London, GB
see more
Employees
Employees
20216% increase
Employees
1,40231% increase
Valuation ($)
Valuation ($)
737.4 m
Valuation ($)
6.3 b

Financial

Revenue (est.)
Revenue (est.)
$49.8m (FY, 2025)
Revenue (est.)
$943.7m (FY, 2025)
Cost of goods
Cost of goods
$274k (FY, 2025)
Cost of goods
$15.9m (FY, 2025)
Gross profit
Gross profit
$49.5m (FY, 2025)
Gross profit
$927.8m (FY, 2025)
Net income
Net income
($50.3m) (FY, 2025)
Net income
($381.4m) (FY, 2025)

Operating

Phase I Trials Products
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
1 (FY, 2023)
Phase III Trials Products
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
17 (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
1,402↑ 31% increase

Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.

View company